Drug Shortage Report for APO-BICALUTAMIDE
Report ID | 20860 |
Drug Identification Number | 02296063 |
Brand name | APO-BICALUTAMIDE |
Common or Proper name | BICLUTAMIDE |
Company Name | APOTEX INC |
Market Status | DORMANT |
Active Ingredient(s) | BICALUTAMIDE |
Strength(s) | 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 BLS |
ATC code | L02BB |
ATC description | HORMONE ANTAGONISTS AND RELATED AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-10-20 |
Actual start date | 2017-09-22 |
Estimated end date | 2018-09-14 |
Actual end date | 2018-08-22 |
Shortage status | Resolved |
Updated date | 2018-08-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v21 | 2018-08-23 | English | Compare |
v22 | 2018-08-23 | French | Compare |